黑料网官网

Founded in 2019, Vanqua Bio is a biopharmaceutical company focused on discovering and developing next-generation medicines for neurodegenerative diseases. Our novel drug-development approach combines advanced insights into critical neuronal cell pathways with cutting-edge assays to advance needed therapies. Our lead program targets glucocerebrosidase (GCase) as a potential treatment for Parkinson鈥檚 disease (PD) and Dementia with Lewy Bodies (DLB). Additional programs address overactivation of the innate immune system in central and peripheral disorders, including Alzheimer鈥檚 disease.